$380.99
8.562.3%
Ult. Agg.: Oct 27, 4:00 PM
Bio-Rad Laboratories (BIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bio-Rad Laboratories (BIO) ha pubblicato l'ultima guidance il agosto 4, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $2.51B - $2.6B per il periodo.
Rispetto alle previsioni precedenti, Bio-Rad Laboratories ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Bio-Rad Laboratories ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Bio-Rad Laboratories. 15
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.86 | $2.14 | $2.65 | $2.08 |
| Actual | $2.62 | $1.89 | $2.51 | $2.26 |
| Surprise | +40.9% | -11.7% | -5.28% | +8.65% |
| Revenue | ||||
| Estimate | $630.7M | $587.4M | $689.9M | $651.3M |
| Actual | $651.0M | $592.1M | $693.2M | $653.0M |
| Surprise | +3.23% | +0.80% | +0.48% | +0.25% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $2.30 | $2.93 | $2.22 |
| Revenue | |||
| Consensus | $652.3M | $698.0M | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $2.62 | $1.86 | 40.9 % |
| Q1 | Apr 30, 2026 | $1.89 | $2.14 | -11.7 % |
| Q4 | Feb 12, 2026 | $2.51 | $2.65 | -5.28 % |
| Q3 | Oct 29, 2025 | $2.26 | $2.08 | 8.65 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $651.00M | $630.66M | 3.23 % |
| Q1 | Apr 30, 2026 | $592.10M | $587.38M | 0.80 % |
| Q4 | Feb 12, 2026 | $693.20M | $689.87M | 0.48 % |
| Q3 | Oct 29, 2025 | $653.00M | $651.35M | 0.25 % |